کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
5628626 1579895 2016 6 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
The effect of lamotrigine and phenytoin on bone turnover and bone strength: A prospective study in Wistar rats
ترجمه فارسی عنوان
اثر لاموتریژین و فنیتوین بر گردش استخوان و استحکام استخوان: یک مطالعه آینده نگر در موش های صحرایی ویستار
موضوعات مرتبط
علوم زیستی و بیوفناوری علم عصب شناسی عصب شناسی
چکیده انگلیسی


- Lamotrigine has no effect on the BMD, BTM or mechanical strength in gonadally intact animals.
- Although a low dose of PHT was associated with enhanced BTM, it did not affect BMD or the biomechanical properties of the bones, similar to the results observed for LTG.
- LTG has no effect on the BMD, BTM or mechanical strength in gonadally intact animals.
- A low dose of PHT was associated with enhanced BTM.
- The low dose of PHT did not affect BMD or the biomechanical properties of the bones.

ObjectiveSome data suggest that exposure to lamotrigine (LTG) might be associated with impaired bone health in an orchidectomized rat model. The aim of this study was to determine if LTG poses any significant risk for bone in a gonadally intact animals and to compare the effect of LTG with that of phenytoin (PHT).MethodTwenty-four rats were divided into control and test groups, (n = 8 per group). Control rats received a standard laboratory diet (SDL), while rats in the test groups were fed a SLD enriched with LTG or PHT for 12 weeks. Dual energy X-ray absorptiometry was used to measure bone mineral density (BMD). The concentrations of bone turnover markers (BTM) were assayed in bone homogenates. The femurs were measured and biomechanically tested.ResultsTreatment with either LTG or PHT had no significant effect on BMD or on the biomechanical strength of the bones. In contrast to the effect of LTG, we did find significant changes in BTM in the PHT group: a highly significant decrease in the osteoprotegerin/receptor activator of nuclear factor kappa B ratio (p < 0.01) and highly significant increases in bone alkaline phosphatase and amino-terminal propeptide of procollagen type I (p < 0.001, p ˂ 0.01, respectively). In the LTG group, the only significant change was a decrease in sclerostin (p ˂ 0.05). The PHT level was 19.0 (15.6-19.5) μmol/l, which represents the lower end of the therapeutic range used in humans. The level of LTG was 60.7 (58.5-61.8) μmol/l.ConclusionsLTG has no effect on the BMD, BTM or mechanical strength in gonadally intact animals. Although a low dose of PHT was associated with enhanced BTM, it did not affect BMD or the biomechanical properties of the bones, similar to the results observed for LTG.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Epilepsy Research - Volume 128, December 2016, Pages 113-118
نویسندگان
, , , , , , , , ,